)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Bastide Le Confort Médical
Bastide Le Confort Médical (BLC) investor relations material
Bastide Le Confort Médical Q4 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2026 TU earnings summary3 Sep, 2026
Executive summary
Annual revenue for 2025-2026 reached €482.9 million, up 7.6% year-over-year, with organic growth at 7.8%.
Revenue excluding the impact of the EXPERF sale was €526 million, surpassing the initial target of €510 million.
The sale of EXPERF on June 1, 2026, led to restated figures for continuing operations.
Financial highlights
Fourth-quarter revenue was €122.2 million, up 6.4% as reported and 6.5% organically, despite a 4% price cut in the sleep apnea segment.
Homecare revenue for the year was €201.7 million, up 5.2%; healthcare institutions revenue was €94.3 million, up 10.5%.
Stores/online revenue reached €107.4 million, up 0.9%, impacted by regulatory changes.
Respiratory business revenue was €177.1 million, up 10.5% as reported and 11.1% organically.
Nutrition-Perfusion-Diabetes-Stomatherapy revenue was €104.2 million, up 7.7%, with Diabetes up 20%.
Outlook and guidance
Recurring operating margin target of around 9% for 2025-2026 is confirmed.
For 2026-2027, revenue is expected to again surpass €500 million, with specific guidance to be announced in October.
Sale of EXPERF expected to reduce expenses and improve financial leverage to below 2.5x post-IFRS 16.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bastide Le Confort Médical
- Nine-month revenue grew 7.0% to €391.9M, led by home healthcare and respiratory segments.BLC
Q3 2026 TU - Net profit jumped to €30.6M on strong revenue growth and asset sales, with leverage down to 2.77x.BLCH1 2026
- Revenue up 8% to €260.4M, with robust growth in home healthcare and respiratory segments.BLCQ2 2026 TU
- Q1 organic revenue up 8.3%, driven by home healthcare and respiratory growth.BLCQ1 2026 TU
- Strong revenue and margin growth, with improved leverage and positive 2025-2026 outlook.BLCH2 2025
- Q1 revenue up 9.1% to €133.8M; 2024-2025 targets and debt reduction focus reaffirmed.BLCQ1 24/25 TU
- Solid revenue and margin gains offset by higher financial costs, with deleveraging prioritized.BLCH2 23/24
- Revenue exceeded targets with strong Q4 growth and robust outlook for 2024-2025.BLCH2 23/24 TU
- Revenue up 8.4% to €419.4M; 2024-2025 targets and strong growth in technical segments confirmed.BLCQ3 2025
Next Bastide Le Confort Médical earnings date
H2 202621 Oct, 2026
Bastide Le Confort Médical
Next Bastide Le Confort Médical earnings date
H2 202621 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage